Dimensional Fund Advisors LP Krystal Biotech, Inc. Transaction History

Dimensional Fund Advisors LP

$403 Billion
Q3 2024

A detailed history of Dimensional Fund Advisors LP transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 600,261 shares of KRYS stock, worth $96.3 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

600,261

Previous 580,452 3.41%

Holding current value

$96.3 Million

Previous $107 Million 2.4%

% of portfolio

0.03%

Previous 0.03%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	BUY	$174.7 - $213.66 $3.46 Million - $4.23 Million	19,809 Added 3.41%	600,261 $109 Million
Q2 2024 Aug 09, 2024	BUY	$153.12 - $183.64 $1.15 Million - $1.38 Million	7,537 Added 1.32%	580,452 $107 Million
Q1 2024 May 10, 2024	BUY	$108.01 - $179.35 $2.39 Million - $3.97 Million	22,109 Added 4.01%	572,915 $102 Million
Q4 2023 Feb 07, 2024	BUY	$96.0 - $128.29 $2.9 Million - $3.87 Million	30,169 Added 5.79%	550,806 $68.3 Million
Q3 2023 Nov 09, 2023	BUY	$108.51 - $130.22 $3.69 Million - $4.43 Million	34,040 Added 7.0%	520,637 $60.4 Million
Q2 2023 Aug 09, 2023	BUY	$78.48 - $130.32 $1.92 Million - $3.19 Million	24,507 Added 5.3%	486,597 $57.1 Million
Q1 2023 May 12, 2023	BUY	$72.39 - $84.27 $5.27 Million - $6.14 Million	72,805 Added 18.7%	462,090 $37 Million
Q4 2022 Feb 09, 2023	BUY	$63.14 - $79.9 $1.92 Million - $2.43 Million	30,448 Added 8.49%	389,285 $30.8 Million
Q3 2022 Nov 10, 2022	BUY	$64.85 - $82.4 $5.38 Million - $6.83 Million	82,914 Added 30.05%	358,837 $25 Million
Q2 2022 Aug 12, 2022	BUY	$48.93 - $73.47 $658,597 - $988,906	13,460 Added 5.13%	275,923 $18.1 Million
Q1 2022 May 13, 2022	BUY	$51.99 - $72.11 $5.81 Million - $8.06 Million	111,822 Added 74.23%	262,463 $17.5 Million
Q4 2021 Feb 09, 2022	SELL	$39.81 - $88.24 $526,407 - $1.17 Million	-13,223 Reduced 8.07%	150,641 $10.5 Million
Q3 2021 Nov 12, 2021	SELL	$52.01 - $71.77 $2.59 Million - $3.58 Million	-49,848 Reduced 23.32%	163,864 $8.56 Million
Q2 2021 Aug 12, 2021	BUY	$62.14 - $81.82 $4.25 Million - $5.59 Million	68,380 Added 47.05%	213,712 $14.5 Million
Q1 2021 May 14, 2021	BUY	$59.42 - $85.46 $4.57 Million - $6.58 Million	76,988 Added 112.65%	145,332 $11.2 Million
Q4 2020 Feb 25, 2021	BUY	$40.64 - $61.38 $2.78 Million - $4.19 Million	68,344 New	68,344 $4.1 Million

Others Institutions Holding KRYS

# of Institutions

310

Shares Held

24.3M

Call Options Held

483K

Put Options Held

364K

View Full List

About Krystal Biotech, Inc.

Ticker KRYS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,664,300
Market Cap $4.12B
Description
Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...

More about KRYS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Account

Dimensional Fund Advisors LP Krystal Biotech, Inc. Transaction History